FDA Inspection 1328788 — FRANKLIN BIOLABS INC
The FDA completed an inspection of FRANKLIN BIOLABS INC on Jul 10, 2026 in King Of Prussia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 10, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- King Of Prussia, PA (United States)